Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 1/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.33 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.32 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | SELP | P16109 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546317 | 1.00 | LGALS9 (0.33) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL4546311 | 0.89 | LGALS8 (0.31) | — | |
| SCHEMBL17590144 | 0.89 | LGALS8 (0.31) | — | |
| SCHEMBL4546283 | 0.86 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL17590142 | 0.79 | ABCB1 (0.33) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL4546312 | 0.79 | ABCB1 (0.33) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL11981202 | 0.79 | USP2 (0.41) | LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL4546306 | 0.79 | LGALS9 (0.40) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL17590139 | 0.79 | LGALS9 (0.40) | LGALS9LGALS1LGALS3LGALS7; LGALS7BABCB1 | |
| SCHEMBL17590157 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255119-B2 | Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereof | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2016-02-09 | — | — | US | disclosed |